These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17580126)

  • 21. Solid organ transplant: medication management issues.
    Trofe J; Wimberley S
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S48-9. PubMed ID: 11029867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
    Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
    Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of stress, distress and feelings of indebtedness on adherence to immunosuppressants following kidney transplantation.
    Achille MA; Ouellette A; Fournier S; Vachon M; Hébert MJ
    Clin Transplant; 2006; 20(3):301-6. PubMed ID: 16824145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonadherence and the transition to adulthood.
    Fredericks EM
    Liver Transpl; 2009 Nov; 15 Suppl 2():S63-9. PubMed ID: 19876953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perceived barriers to adherence among adolescent renal transplant candidates.
    Zelikovsky N; Schast AP; Palmer J; Meyers KE
    Pediatr Transplant; 2008 May; 12(3):300-8. PubMed ID: 18194352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Awareness of memory impairment increases the adherence to immunosuppressants in kidney transplant recipients.
    Cheng CY; Lin BY; Chang KH; Shu KH; Wu MJ
    Transplant Proc; 2012 Apr; 44(3):746-8. PubMed ID: 22483484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes after liver transplantation in children.
    Bucuvalas JC; Alonso E
    Curr Opin Organ Transplant; 2008 Jun; 13(3):247-51. PubMed ID: 18685311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics.
    Wang HY; Chan AL; Chen MT; Liao CH; Tian YF
    Transplant Proc; 2008 Sep; 40(7):2319-23. PubMed ID: 18790223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adherence to therapy in sub-Saharan non-dialysed patients with chronic kidney diseases].
    Seck SM; Elhadj FK; Fall S; Cissé MM; Dia D; Guèye S; Pouye A; Niang A; Diouf B
    Nephrol Ther; 2008 Oct; 4(5):325-9. PubMed ID: 18417441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom experience after lung transplantation: impact on quality of life and adherence.
    Kugler C; Fischer S; Gottlieb J; Tegtbur U; Welte T; Goerler H; Simon A; Haverich A; Strueber M
    Clin Transplant; 2007; 21(5):590-6. PubMed ID: 17845632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy.
    Chisholm MA; Kwong WJ; Spivey CA
    Transplantation; 2007 Nov; 84(9):1145-50. PubMed ID: 17998870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonadherence in asthmatic patients: is there a solution to the problem?
    Bender B; Milgrom H; Rand C
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):177-85; quiz 185-6. PubMed ID: 9305223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of renal transplantation.
    Hashmi S; Poommipanit N; Kahwaji J; Bunnapradist S
    Minerva Med; 2007 Dec; 98(6):713-29. PubMed ID: 18299684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological factors associated with medication adherence following renal transplantation.
    Gremigni P; Bacchi F; Turrini C; Cappelli G; Albertazzi A; Bitti PE
    Clin Transplant; 2007; 21(6):710-5. PubMed ID: 17988263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-adherence to post-transplant care: prevalence, risk factors and outcomes in adolescent liver transplant recipients.
    Berquist RK; Berquist WE; Esquivel CO; Cox KL; Wayman KI; Litt IF
    Pediatr Transplant; 2008 Mar; 12(2):194-200. PubMed ID: 18307668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice.
    Haverkamp F; Johansson L; Dumas H; Langham S; Tauber M; Veimo D; Chiarelli F
    Clin Ther; 2008 Feb; 30(2):307-16. PubMed ID: 18343269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.